Since 2002, twenty- five patients affected by breast cancer, for whom extensive lung/ heart involvement was expected from conventional techniques, were irradiated with intensity modulated photon beams ( IMRT). For 10 patients the internal mammary lymphatic chain was included in the target, 6 patients received treatment of the thoracic wall after mastectomy and 9 patients were treated after breast conserving surgery. Dose prescription ranged between 48.6 and 50 Gy at 1.8 or 2 Gy per fraction. The target volume ( PTV) ranged from 194 to 2121 cm (3). For all cases a Dose Volume Histogram analysis has been conducted on omolateral lung, heart, contralateral lung and breast, healthy tissue and PTV. For PTV the volume receiving more than 90% of the prescribed dose ( V-90%) was 95.8 +/- 1.8% while V-107% = 5.3 +/- 2.8%. The mean dose computed for the heart was 10.4 +/- 2.9 Gy, for the omolateral lung: 13.3 +/- 2.8 Gy, for the contralateral breast: 3.4 +/- 1.8 Gy, for the contralateral lung: 4.6 +/- 2.7 Gy. For the omolateral lung V-20Gy = 23.1 +/- 7.0% and V-45Gy = 0.8 +/- 0.9 Gy. With a short mean follow up of 10.4 months, no pulmonary or cardiac complications were observed. IMRT proved to be technically feasible on a clinical basis for the treatment of the whole breast, including internal mammary chain, or of the thoracic wall after mastectomy.